These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 24661566)

  • 1. Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies.
    Bell JA; Kivimaki M; Hamer M
    Obes Rev; 2014 Jun; 15(6):504-15. PubMed ID: 24661566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of future depression in people who are obese but metabolically healthy: the English longitudinal study of ageing.
    Hamer M; Batty GD; Kivimaki M
    Mol Psychiatry; 2012 Sep; 17(9):940-5. PubMed ID: 22525487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TyG Index Change Is More Determinant for Forecasting Type 2 Diabetes Onset Than Weight Gain.
    Navarro-González D; Sánchez-Íñigo L; Fernández-Montero A; Pastrana-Delgado J; Martinez JA
    Medicine (Baltimore); 2016 May; 95(19):e3646. PubMed ID: 27175686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of metabolically healthy obesity with depressive symptoms: pooled analysis of eight studies.
    Jokela M; Hamer M; Singh-Manoux A; Batty GD; Kivimäki M
    Mol Psychiatry; 2014 Aug; 19(8):910-4. PubMed ID: 24296976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolically Healthy/Unhealthy Overweight/Obesity Associations With Incident Heart Failure in Postmenopausal Women: The Women's Health Initiative.
    Cordola Hsu AR; Xie B; Peterson DV; LaMonte MJ; Garcia L; Eaton CB; Going SB; Phillips LS; Manson JE; Anton-Culver H; Wong ND;
    Circ Heart Fail; 2021 Apr; 14(4):e007297. PubMed ID: 33775111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordant risk: overweight and cardiometabolic risk in Chinese adults.
    Gordon-Larsen P; Adair LS; Meigs JB; Mayer-Davis E; Herring A; Yan SK; Zhang B; Du S; Popkin BM
    Obesity (Silver Spring); 2013 Jan; 21(1):E166-74. PubMed ID: 23505200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty liver index is a risk determinant of incident type 2 diabetes in a metabolically healthy population with obesity.
    Jung CH; Kang YM; Jang JE; Hwang JY; Kim EH; Park JY; Kim HK; Lee WJ
    Obesity (Silver Spring); 2016 Jun; 24(6):1373-9. PubMed ID: 27112320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in Taiwan.
    Hwang LC; Bai CH; Sun CA; Chen CJ
    Asia Pac J Clin Nutr; 2012; 21(2):227-33. PubMed ID: 22507609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.
    Elías-López D; Vargas-Vázquez A; Mehta R; Cruz Bautista I; Del Razo Olvera F; Gómez-Velasco D; Almeda Valdes P; Aguilar-Salinas CA;
    BMC Endocr Disord; 2021 Apr; 21(1):85. PubMed ID: 33910543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).
    Wildman RP; Muntner P; Reynolds K; McGinn AP; Rajpathak S; Wylie-Rosett J; Sowers MR
    Arch Intern Med; 2008 Aug; 168(15):1617-24. PubMed ID: 18695075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolically healthy obesity, transition to unhealthy phenotypes, and type 2 diabetes in 0.5 million Chinese adults: the China Kadoorie Biobank.
    Song Z; Gao M; Lv J; Yu C; Guo Y; Bian Z; Wei Y; Yang L; Du H; Chen Y; Zhang J; Yao J; Chen J; Chen Z; Huang T; Li L;
    Eur J Endocrinol; 2022 Jan; 186(2):233-244. PubMed ID: 34874895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study.
    Soriguer F; Gutiérrez-Repiso C; Rubio-Martín E; García-Fuentes E; Almaraz MC; Colomo N; Esteva de Antonio I; de Adana MS; Chaves FJ; Morcillo S; Valdés S; Rojo-Martínez G
    J Clin Endocrinol Metab; 2013 Jun; 98(6):2318-25. PubMed ID: 23559087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trajectories of fasting glucose and glycated haemoglobin in obese and non-obese incident diabetes: Results from two large cohort studies.
    Yu HJ; Ho M; Chau PH; Fong DYT
    Diabetes Obes Metab; 2023 Oct; 25(10):2835-2845. PubMed ID: 37336785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of metabolically unhealthy normal-weight individuals: Risk factors and their associations with type 2 diabetes.
    Eckel N; Mühlenbruch K; Meidtner K; Boeing H; Stefan N; Schulze MB
    Metabolism; 2015 Aug; 64(8):862-71. PubMed ID: 25861921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effect of obesity and cardio-metabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies.
    Fan J; Song Y; Chen Y; Hui R; Zhang W
    Int J Cardiol; 2013 Oct; 168(5):4761-8. PubMed ID: 23972953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic health is a more important determinant for diabetes development than simple obesity: a 4-year retrospective longitudinal study.
    Rhee EJ; Lee MK; Kim JD; Jeon WS; Bae JC; Park SE; Park CY; Oh KW; Park SW; Lee WY
    PLoS One; 2014; 9(5):e98369. PubMed ID: 24870949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable patterns of obesity and cardiometabolic phenotypes and their association with lifestyle factors in the Di@bet.es study.
    Gutiérrez-Repiso C; Soriguer F; Rojo-Martínez G; García-Fuentes E; Valdés S; Goday A; Calle-Pascual A; López-Alba A; Castell C; Menéndez E; Bordiú E; Delgado E; Ortega E; Pascual-Manich G; Urrutia I; Mora-Peces I; Vendrell J; Vázquez JA; Franch J; Girbés J; Castaño L; Serrano-Ríos M; Martínez-Larrad MT; Catalá M; Carmena R; Gomis R; Casamitjana R; Gaztambide S
    Nutr Metab Cardiovasc Dis; 2014 Sep; 24(9):947-55. PubMed ID: 24984822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese.
    Fingeret M; Marques-Vidal P; Vollenweider P
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):1036-1044. PubMed ID: 30139688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes risk among overweight and obese metabolically healthy young adults.
    Twig G; Afek A; Derazne E; Tzur D; Cukierman-Yaffe T; Gerstein HC; Tirosh A
    Diabetes Care; 2014 Nov; 37(11):2989-95. PubMed ID: 25139886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolically Healthy Obesity and Ischemic Heart Disease: A 10-Year Follow-Up of the Inter99 Study.
    Hansen L; Netterstrøm MK; Johansen NB; Rønn PF; Vistisen D; Husemoen LLN; Jørgensen ME; Rod NH; Færch K
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1934-1942. PubMed ID: 28323999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.